Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Onyema Ogbuagu(Brigham and Women's Hospital), Jason Flamm(Maple Leaf Medical Clinic), Yongwu Shao(Gilead Sciences (United States)), Taylor Donovan, Indira Brar(Henry Ford Hospital), Ramin Ebrahimi(Gilead Sciences (United States)), Frederick Cruickshank, Susanne Doblecki‐Lewis(University of Maryland, Baltimore), Paul Benson, Alexander Kintu(Harvard Global Health Institute), Andrea Antinori(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Amanda Clarke, Catherine Creticos, Joseph de Wet, Gary Whitlock(Mortimer Market Centre), Mezgebe Berhe, David M. Asmuth(University of California, Davis), Christoph D. Spinner(TUM Klinikum), Olamide Dosekun(St Thomas' Hospital), David A. Wohl(University of North Carolina at Chapel Hill), Jared M. Baeten(University of Washington), Ann Avery(MetroHealth), Christoph C Carter(Centre for the AIDS Programme of Research in South Africa), Richard Gilson(University College London), Vanessa Apea(Queen Mary University of London), Moupali Das(University of California, San Francisco), Colm Bergin, Gitte Kronborg(Centre for Prevention and Control of AIDS and Infectious Diseases), Eric S. Daar(UCLA Medical Center), Megan Coleman, Stephanie Cox, Peter Ruane, William D. Dinges, Jason Brunetta(Maple Leaf Medical Clinic), Gordon Crofoot(Clinical Research Organization), Laura Salazar(University College London Hospitals NHS Foundation Trust), Edwin DeJesus(Orlando Immunology Center), Daniel Podzamczer(Bellvitge University Hospital), J Coll, Diana M. Brainard(Gilead Sciences (United States)), Éric Cua(Hôpital l'Archet), Cynthia Brinson, Keith Henry(Universität Hamburg), Jeffrey H. Burack, Thomas L. Campbell, Manuel Crespo Casal, Michelle Cespedes(Icahn School of Medicine at Mount Sinai)
Cited by 91
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k